Top accelerator startups

Startups14,448Programs29

14,448 startups · 29 programs

Evolvere BioSciences

Active · Making Next-Generation Antibiotics that Outpace Bacterial Evolution

WebsiteYC profile

Why it ranks

How the rank works
7signal of 100 · rising 3
  • went through YCProgram · this site+4
  • team of 3Team size · YC's directory+3.1

A sum of public facts, not a judgement and not investment advice.

Competitors

OtherMytosShared: human cell, biotechnology, globalYC S18LondonStartup →AIInactiveResistanceBioShared: ai-powered drug discovery, resistance, therapeuticsYC W19San FranciscoStartup →OtherPhagosShared: biotechnology, antibiotic, resistantEF 2021ParisStartup →
Companies closest to Evolvere BioSciences
Company
MytosShared: human cell, biotechnology, globalYC S18ActiveOther
ResistanceBioShared: ai-powered drug discovery, resistance, therapeuticsYC W19InactiveAI
PhagosShared: biotechnology, antibiotic, resistantEF 2021Not statedOther

Adjacent

OtherAlixiaShared: therapeutics, biotechnology, resistanceYC W22San FranciscoStartup →OtherSensible BiotechnologiesShared: therapeutics, biotechnology, cellYC S21OxfordStartup →AISFA TherapeuticsShared: ai-powered drug discovery, biotechnology, humanYC S21PhiladelphiaStartup →AISerinus BiosciencesShared: therapeutics, biotech, resistanceYC S22New York CityStartup →AIAltay TherapeuticsShared: ai-powered drug discovery, therapeutics, biotechYC W20San FranciscoStartup →
Companies next to Evolvere BioSciences
Company
AlixiaShared: therapeutics, biotechnology, resistanceYC W22ActiveOther
Sensible BiotechnologiesShared: therapeutics, biotechnology, cellYC S21ActiveOther
SFA TherapeuticsShared: ai-powered drug discovery, biotechnology, humanYC S21ActiveAI
Serinus BiosciencesShared: therapeutics, biotech, resistanceYC S22ActiveAI
Altay TherapeuticsShared: ai-powered drug discovery, therapeutics, biotechYC W20ActiveAI

Also from S24 in AI

All of S24
AIÅngström AIGen AI molecular simulations that reproduce wetlab resultsYC S24San FranciscoStartup →AIAminoAnalyticaThe AI scientist for always-on biodefenseYC S24LondonStartup →AIAnthrogenWe work on generalizable tools for the next era of biotech.YC S24San FranciscoStartup →AIInactiveBaseline AIAI document creation and data management for clinical trialsYC S24San FranciscoStartup →AILigo BiosciencesEnzyme design models.YC S24San FranciscoStartup →AIUndermindAn AI agent for scientific researchYC S24San FranciscoStartup →
Company
Ångström AIGen AI molecular simulations that reproduce wetlab resultsteam of 5ActiveAI
AminoAnalyticaThe AI scientist for always-on biodefenseteam of 3ActiveAI
AnthrogenWe work on generalizable tools for the next era of biotech.team of 15hiringActiveAI
Baseline AIAI document creation and data management for clinical trialsteam of 2InactiveAI
Ligo BiosciencesEnzyme design models.team of 4ActiveAI
UndermindAn AI agent for scientific researchActiveAI, Data

Founders

  • Adam WinnifrithFounder/CEO
  • Piotr JedryszekFounder/CTO
  • Weronika SlesakFounder

About Evolvere BioSciences

🦠🤖 We use our computational models to make next-generation antibiotics that outcompete bacterial evolution and precisely target pathogenic bacteria, without harming good microbes or human cells. ☠️ Current antibiotics stop working because bacteria evolve resistance to them. This makes drug-resistant bacteria a looming global health crisis - already killing more people than malaria and AIDS and it is getting exponentially worse 📈. 🧬 Our approach leverages co-evolutionary protein-protein interaction datasets combined with AI to forecast bacterial mutations and create ‘future-proof’ antibiotics, addressing antibiotic resistance before it develops. This changes the game for how frequently society will need to make new antibiotics and how long our new antibiotics will be able to treat patients 👩‍⚕️. We are a team of biochemists and evolutionary biologists who met at the University of Oxford.

YC batch
S24 · Summer 2024
Status, per YC
Active
Category
AI
Team size
3
Location
Oxford, England, United Kingdom
Founded
2021
Checked
7h ago

YC tags: AI-powered Drug Discovery, Biotech, Therapeutics, AI, Biotechnology

Changes seen

TagsOct 19, 2026

Newly tagged AI; no longer tagged Artificial Intelligence.

Source ↗

Evolvere BioSciences in S24: 248 companies, 85% AI

Evolvere BioSciences: questions

Which YC batch was Evolvere BioSciences in?

Evolvere BioSciences was in Y Combinator's Summer 2024 batch (S24).

Is Evolvere BioSciences still active?

Y Combinator lists Evolvere BioSciences as active.

Who founded Evolvere BioSciences?

Evolvere BioSciences's founders, as listed on its YC page: Adam Winnifrith (Founder/CEO), Piotr Jedryszek (Founder/CTO), Weronika Slesak (Founder).

Where is Evolvere BioSciences based?

Evolvere BioSciences lists Oxford, England, United Kingdom as its location on YC's directory.